Skip to main content

Spero Therapeutics, Inc.

SPRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001701108

No open-market purchases or sales by Spero Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $47.5M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Spero Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
−2 vs. Q3 2023
Shares held
13.8M
+1.25M (+9.9%) vs. Q3 2023
Total value
$143.0M
+$127.8M (+839.6%) vs. Q3 2023
New holders
6
10 more added
Sold out
8
10 more reduced

2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SPRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 50 institutions
Q1 2021: 94 institutionsQ2 2021: 88 institutionsQ3 2021: 87 institutionsQ4 2021: 84 institutionsQ1 2022: 100 institutionsQ2 2022: 79 institutionsQ3 2022: 69 institutionsQ4 2022: 60 institutionsQ1 2023: 48 institutionsQ2 2023: 56 institutionsQ3 2023: 54 institutionsQ4 2023: 50 institutionsQ1 2024: 54 institutionsQ2 2024: 48 institutionsQ3 2024: 46 institutionsQ4 2024: 50 institutionsQ1 2025: 38 institutionsQ2 2025: 44 institutionsQ3 2025: 47 institutionsQ4 2025: 56 institutionsQ1 2026: 50 institutionsQ2 2026: 59 institutions
Value heldQ4 2023: $143.1M
Q1 2021: $273.1MQ2 2021: $244.1MQ3 2021: $338.2MQ4 2021: $318.3MQ1 2022: $179.6MQ2 2022: $15.5MQ3 2022: $39.7MQ4 2022: $24.6MQ1 2023: $25.5MQ2 2023: $20.8MQ3 2023: $17.2MQ4 2023: $143.1MQ1 2024: $23.7MQ2 2024: $18.0MQ3 2024: $16.5MQ4 2024: $16.5MQ1 2025: $10.9MQ2 2025: $32.1MQ3 2025: $21.3MQ4 2025: $49.2MQ1 2026: $49.3MQ2 2026: $47.5M
Institutions holding SPRO and their total value by quarter
QuarterHoldersValue
Q2 202659$47.5M
Q1 202650$49.3M
Q4 202556$49.2M
Q3 202547$21.3M
Q2 202544$32.1M
Q1 202538$10.9M
Q4 202450$16.5M
Q3 202446$16.5M
Q2 202448$18.0M
Q1 202454$23.7M
Q4 202350$143.1M
Q3 202354$17.2M
Q2 202356$20.8M
Q1 202348$25.5M
Q4 202260$24.6M
Q3 202269$39.7M
Q2 202279$15.5M
Q1 2022100$179.6M
Q4 202184$318.3M
Q3 202187$338.2M
Q2 202188$244.1M
Q1 202194$273.1M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Spero Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding SPRO in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Novo Holdings A/S468,902$123.4M7.62%00.0%Unchanged
Anson Funds Management LP4,297,699$6.32M1.22%+138,127+3.3%Added
Vanguard Group Inc1,643,757$2.42M0.00%+86,161+5.5%Added
ADAR1 Capital Management, LLC1,067,711$1.57M0.70%+1,067,711New
Atlas Venture Life Science Advisors, LLC1,013,438$1.49M0.18%00.0%Unchanged
Alphabet Inc.889,979$1.31M0.06%00.0%Unchanged
Murchinson Ltd.862,700$1.27M0.22%00.0%Unchanged
Renaissance Technologies LLC547,465$805.0K0.00%+300+0.1%Added
BlackRock Inc.480,599$706.5K0.00%−1,210−0.3%Reduced
Geode Capital Management, LLC412,707$606.8K0.00%00.0%Unchanged
Ameriprise Financial Inc402,963$592.4K0.00%−60,678−13.1%Reduced
Acadian Asset Management LLC343,856$505.0K0.00%+71,832+26.4%Added
AWM Investment Company, Inc.333,400$490.1K0.06%00.0%Unchanged
Millennium Management LLC148,857$218.8K0.00%+29,163+24.4%Added
Bridgeway Capital Management, LLC134,800$198.2K0.00%00.0%Unchanged
State Street Corp130,511$191.9K0.00%00.0%Unchanged
DAFNA Capital Management LLC125,000$183.8K0.04%00.0%Unchanged
Squarepoint Ops LLC122,802$180.5K0.00%−6,695−5.2%Reduced
Northern Trust Corp88,881$130.7K0.00%00.0%Unchanged
XTX Topco Ltd65,966$97.0K0.02%+7,598+13.0%Added
Citadel Advisors LLC32,274$47.4K0.00%+32,274New
DLK Investment Management, LLC31,355$46.1K0.02%+31,355New
Charles Schwab Investment Management Inc28,565$42.0K0.00%00.0%Unchanged
Prudential Financial Inc28,200$41.5K0.00%00.0%Unchanged
Mackenzie Financial Corp21,462$31.5K0.00%+4,264+24.8%Added
Susquehanna International Group, LLP18,086$26.6K0.00%−2,097−10.4%Reduced
Bourgeon Capital Management LLC15,100$22.2K0.00%00.0%Unchanged
Three Seasons Wealth, LLC15,000$22.1K0.02%+15,000New
Morgan Stanley12,035$17.7K0.00%+3,047+33.9%Added
Two Sigma Securities, LLC10,301$15.1K0.00%+10,301New
Dimensional Fund Advisors LP10,003$14.7K0.00%−1,750−14.9%Reduced
Texas Yale Capital Corp.10,000$14.7K0.00%00.0%Unchanged
Russell Investments Group, Ltd.6,400$9.41K0.00%00.0%Unchanged
Bank of America Corp5,750$8.45K0.00%−3,032−34.5%Reduced
Group One Trading, L.P.4,590$6.75K0.00%−29,600−86.6%Reduced
Federation des caisses Desjardins du Quebec730$1.07K0.00%00.0%Unchanged
Allworth Financial LP600$8820.00%00.0%Unchanged
Wells Fargo & Company533$7840.00%+18+3.5%Added
Rhumbline Advisers458$6730.00%00.0%Unchanged
UBS Group AG329$4840.00%−26,806−98.8%Reduced
JPMorgan Chase & Co236$3470.00%00.0%Unchanged
FMR LLC189$2780.00%+189New
US Bancorp151$2220.00%00.0%Unchanged
GWM Advisors LLC100$1470.00%00.0%Unchanged
Advisor Group Holdings, Inc.97$1430.00%00.0%Unchanged
PFS Partners, LLC50$740.00%−200−80.0%Reduced
BNP Paribas Arbitrage, SA12$180.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1$10.00%−571−99.8%Reduced
Qube Research & Technologies Ltd1$10.00%00.0%Unchanged
Royal Bank of Canada315$00.00%+15+5.0%Added
Rock Springs Capital Management LP0$00.00%−57,373−100.0%Sold out
HRT Financial LP0$00.00%−18,627−100.0%Sold out
Two Sigma Investments, LP0$00.00%−17,023−100.0%Sold out
ERn Financial, LLC0$00.00%−15,766−100.0%Sold out
WR Wealth Planners, LLC0$00.00%−2,600−100.0%Sold out
Cullen/Frost Bankers, Inc.0$00.00%−2,000−100.0%Sold out
Beaird Harris Wealth Management, LLC0$00.00%−202−100.0%Sold out
Heritage Wealth Advisors0$00.00%−187−100.0%Sold out
Atlas Venture Associates IX, LLC––––Not filed
OUP Management Co., LLC––––Not filed